Beacon Therapeutics
Beacon Therapeutics is a clinical-stage biotech company developing gene therapies for severe retinal diseases like X-linked retinitis pigmentosa and geographic atrophy. Founded in 2023 and based in London, it has raised $365M in Series C funding and employs 96 people.
The growth story
Beacon Therapeutics grew from 4 to 96 employees between 2021 and 2026, raising $365M along the way, most recently a Series C in January 2026.
About
Beacon Therapeutics develops gene therapies targeting rare and prevalent eye diseases that cause blindness. Its pipeline focuses on retinal conditions including X-linked retinitis pigmentosa and geographic atrophy secondary to age-related macular degeneration.
The company raised $365M in Series C funding in January 2026, a notable amount for a biotech firm just three years old. Its 96 employees suggest rapid scaling since its 2023 founding, though headcount growth rates are not available.
Founders and leadership
Beacon Therapeutics is led by a research-heavy organization, with research being the largest function. The company has a median tenure of 2 years, indicating relatively recent hires across the organization.
The Beacon Therapeutics org chart
Lance Baldo (Chief Executive Officer) leads 57 mapped leaders with 18 direct reports. Click +N to expand a team; names link to the person’s public profile.
- Vice President, Head of Program Strategy and Chief of Staff to the CEOExecutive
Departments, and which ones grew
Headcount by function: Research 21 (-5% YoY), Business Development 15 (+7% YoY), Healthcare Services 7 (+17% YoY), Quality Assurance 7 (0% YoY), Human Resources 6 (0% YoY), Legal 5 (+25% YoY).
Talent flow
Beacon Therapeutics draws heavily from AGTC and Gyroscope Therapeutics, with 26 and 15 hires respectively. Other notable talent sources include Genentech, Novartis, and GSK. Alumni frequently move to Ascend Advanced Therapies, with 11 former employees joining the company.
Most common previous employers of Beacon Therapeutics staff: AGTC (26), Gyroscope Therapeutics (15), Genentech (6), Novartis (6), GSK (4), Roche (3). Former Beacon Therapeutics employees most often moved to Ascend Advanced Therapies (11), Verdiva Bio (2), EyeBio (2), University of Florida College of Medicine (2), Protara Therapeutics (1), Vantage Biosciences (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Beacon Therapeutics: Biotechnology (31), Project Management (28), Microsoft Office (25), Pharmaceutics (25), Clinical Trials (24), Leadership (23), Microsoft Excel (23), Clinical Research (23).
Where the team actually sits
Beacon Therapeutics people are concentrated in England, United Kingdom (14), Greater Boston (10), Florida, United States (9), Massachusetts, United States (7).
Search footprint
Beacon Therapeutics attracts about 440 organic search visits a month, traffic worth roughly $3K a month if bought through ads. It gained 48 ranking keywords and lost 28 in the last period.
What employees say
- Compensation
- 4.10 / 5
- Career opportunities
- 3.90 / 5
- Senior management
- 4.30 / 5
- Work-life balance
- 4.30 / 5
Frequently asked
Beacon Therapeutics has 96 employees as of September 2026.
Beacon Therapeutics has raised $365M in total, most recently a Series C round in January 2026.
Beacon Therapeutics was founded in 2023 by Robert MacLaren.
Lance Baldo (Chief Executive Officer) sits at the top of Beacon Therapeutics's reporting structure, with 18 direct reports.
The most common previous employers of current Beacon Therapeutics staff are AGTC (26 people), Gyroscope Therapeutics (15 people), Genentech (6 people).
Former Beacon Therapeutics employees most often move to Ascend Advanced Therapies (11), Verdiva Bio (2), EyeBio (2).
Beacon Therapeutics attracts about 440 organic search visits a month, worth roughly $3K a month in equivalent ad spend.
The most common skills among Beacon Therapeutics staff are Biotechnology, Project Management, Microsoft Office, Pharmaceutics, Clinical Trials.
Beacon Therapeutics staff are concentrated in England, United Kingdom (14), Greater Boston (10), Florida, United States (9).
Beacon Therapeutics has about 21 people in Research, down 5% over the past year, as of September 2026.
Beacon Therapeutics has about 15 people in Business Development, up 7% over the past year, as of September 2026.
Computed from 83 current and 59 former Beacon Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.